Optimization of empirical antibiotic selection for suspected Gram-negative bacteraemia in the emergency department

International Journal of Antimicrobial Agents

Volumn 25, Issue 5, 2005, Pages 398-403

  Benenson, Shmuel ^a,b   Yinnon, Amos M ^a,b   Schlesinger, Yechiel ^a,b   Rudensky, Bernard ^a,b   Raveh, David ^a,b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bacteraemia; Empirical therapy; Gram negative bacteria

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BLOOD CULTURE; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; EMERGENCY WARD; EMPIRICAL RESEARCH; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; FOREIGN BODY; GRAM NEGATIVE SEPSIS; HOSPITALIZATION; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NURSING HOME; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 17644396633     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.01.019     Document Type: Conference Paper

References (33)

1. N.J. Norman Sepsis R.F. Betts S.W. Chapman R.L. Penn A practical approach to infectious diseases 5th ed. 2003 Little Brown Philadelphia 48 54
2. L.S. Young Sepsis syndrome G.L. Mandell J.E. Bennett R. Dolin Principles and practice of infectious diseases 5th ed. 2000 Churchill Livingstone Philadelphia 806 819
3. S. Chamberland, J. L'Ecuyer, and C. Lessard Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group Clin Infect Dis 15 1992 615 628
4. A.M. Ristuccia, and B.A. Cunha The aminoglycosides Med Clin North Am 66 1982 303 312
5. H.C. Neu Clinical use of aminoglycosides A. Whelton H.C. Neu The aminoglycosides 1982 Marcel Dekker New York 611 628
6. J. Modai Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Sroup Am J Med 30 1989 243S 247S
7. N.P. Quintero-Perez, J.F. Andrade-Villaneuva, and G. Leon-Garnica Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime Am J Med 30 1989 198S 201S
8. R.G. Finch Ciprofloxacin: efficacy and indications J Chemother 12 1 2000 5 7
9. S. Harbath, J. Garbino, and J. Pugin Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis Am J Med 115 2003 529 535
10. G. Elhanan, M. Sarhat, and R. Raz Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteremia due to urinary tract infection J Infect 35 1997 283 288
11. L. Leibovici, I. Shraga, and M. Drucker The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection J Intern Med 244 1998 379 386
12. M.H. Kollef, G. Sherman, S. Ward, and V.J. Fraser Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 1999 462 474
13. R.D. MacArthur, M. Miller, and T. Albertson Adequacy of empiric antbiotic treatment and survival in severe sepsis: experience from the MONARCS trial Clin Infect Dis 38 2004 284 288
14. A.M. Yinnon, Y. Schlesinger, D. Gabbay, and B. Rudensky Analysis of five years of bacteremias: importance of stratification of microbial susceptibilities by source of patients J Infect 35 1997 17 23
15. D. Raveh, D. Rudensky, Y. Schlesinger, D. Attias, and A.M. Yinnon Trends in bacteremias: analysis of 7544 patient-specific bacteremic episodes spanning 11 years (1990-2000) J Hosp Infect 55 2003 196 203
16. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. 10th informational supplement. NCCLS document M100-S10. Wayne, PA: NCCLS; 2000.
17. W.A. Knaus, D.P. Wagner, and E.A. Draper The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults Chest 100 1991 1619 1636
18. M. Antonelli, G. Mercurio, S. Di Nunno, G. Recchioni, and G. DeAngelis De-escalation antimicrobial chemotherapy in critically ill patients: pros and cons J Chemother 13 2001 218 223
19. D. Raveh, Y. Levy, and Y. Schlesinger Longitudinal surveillance of antibiotic use in the hospital; Indications for, and management of antimicrobial agents Quart J Med 94 2001 141 152
20. P.P. Gleason, T.P. Meehan, J.M. Fine, D.H. Galusha, and M.J. Fine Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia Arch Intern Med 159 1999 2562 2572
21. D.S. Battleman, M. Callahan, and H.T. Thaler Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization Arch Intern Med 162 2002 682 688
22. D.J. Diekema, M.A. Pfaller, and R.N. Jones Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program 1997 Clin Infect Dis 29 1999 595 607
23. J. Osteo, J. Campos, and F. Baquero and Spanish members of the European Antimicrobial Resistance Surveillance System (EARSS) J Antimicrob Chemother 50 2002 945 952
24. Y. Siegman-Igra, B. Fourer, and R. Orni-Wasserlauf Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia Clin Infect Dis 34 2002 1431 1439
25. C. Pena, J.M. Albareda, and R. Pallares Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections Antimicrob Agents Chemother 39 1995 520 524
26. J.M. Lynch, G.R. Hodges, G.M. Clark, and D.L. Dworzack Gram-negative bacteremias. Analysis of factors for clinical assessment of gentamicin resistance Arch Intern Med 141 1981 582 586
27. L. Leibovici, H. Konisberger, S.D. Pitlik, Z. Samra, and M. Drucker Predictive index for optimizing empiric treatment of Gram-negative bacteremia J Infect Dis 163 1991 193 196
28. J. Wiener, J.P. Quinn, and P.A. Bradford Multiple antibiotic-resistant klebsiella and Escherichia coli in nursing homes JAMA 281 1999 517 523
29. R.P. Gaynes, R.A. Weinstein, W. Chamberlin, and S.A. Kabins Antibiotic-resistant flora in nursing home patients admitted to the hospital Arch Intern Med 145 1985 1804 1807
30. R.R. Muder, C. Brennen, S.D. Drenning, J.E. Stout, and M.M. Wagener Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use Infect Control Hosp Epidemiol 18 1997 809 813
31. R. Friedmann, R. Hamburger, C. Shulman, A.M. Yinnon, and D. Raveh Antimicrobial susceptibilities of urinary pathogens in a multidisciplinary long-term care facility Diagn Microbiol Infect Dis 46 2003 217 222
32. M. Bonadio, M. Meini, P. Spitaleri, and C. Gigli Current microbiological and clinical aspects of urinary tract infections Eur Urol 40 2001 439 444
33. L. Leibovici, S. Greenshtain, O. Cohen, and A.J. Wysenbeek Toward improved empiric management of moderate to severe urinary tract infections Arch Intern Med 152 1992 2481 2486